What is B-Secur?
B-Secur is a specialized medical technology firm dedicated to advancing heart health through its innovative HeartKey solutions. At the core of its product suite is HeartKey Rhythm, an FDA-cleared universal ECG analytics software designed to provide high-fidelity rhythm detection and actionable clinical insights. By focusing on the intersection of biometric security and cardiac monitoring, B-Secur provides healthcare providers with the tools necessary to improve diagnostic accuracy and operational efficiency. The platform is engineered for versatility, supporting both cloud-based and device-level deployments, which ensures that critical cardiac data remains accessible and actionable across diverse clinical environments.
How much funding has B-Secur raised?
B-Secur has raised a total of $25.7M across 4 funding rounds:
Other Financing Round
$3.9M
Angel/Seed
$4.6M
Unspecified
$5.3M
Other Financing Round
$12M
Other Financing Round (2015): $3.9M with participation from Rudolf Wolff
Angel/Seed (2017): $4.6M led by Woodford Investment Management, Kernel Capital, British Business Bank, and Accelerated Digital Ventures
Unspecified (2019): $5.3M supported by Kernel Capital and Accelerated Digital Ventures
Other Financing Round (2021): $12M featuring First Capital Ventures
Key Investors in B-Secur
Kernel Capital
Kernel Capital is a venture capital and private equity firm that specializes in investing in growth stage and early stage companies, providing both capital and strategic guidance to support scaling.
Accelerated Digital Ventures
Accelerated Digital Ventures Ltd is a firm operating in the custom software and IT services industry, focusing on supporting technology-driven businesses.
First Capital Ventures
First Capital Ventures is an investment group specializing in healthcare and digital health technologies, utilizing a network of accredited investors to support platform-driven innovation.
What's next for B-Secur?
With the recent influx of capital, B-Secur is well-positioned to accelerate its product roadmap and expand its footprint in the competitive cardiac monitoring market. The strategic focus will likely center on deepening the clinical utility of the HeartKey platform, potentially through enhanced AI-driven analytics and broader interoperability with existing hospital information systems. As the demand for remote patient monitoring and digital health solutions continues to rise, B-Secur is poised to leverage its technological edge to capture significant market share. Future efforts will likely prioritize scaling commercial partnerships and navigating the regulatory landscapes of new international markets to ensure the widespread adoption of its cardiac analytics software.
See full B-Secur company page
